Crossmark Global Holdings’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-9,612
Closed -$216K – 1290
2024
Q2
$216K Sell
9,612
-1,059
-10% -$27.7K ﹤0.01% 1204
2024
Q1
$280K Buy
10,671
+171
+2% +$4.87K 0.01% 1129
2023
Q4
$331K Sell
10,500
-847
-7% -$23K 0.01% 1016
2023
Q3
$298K Sell
11,347
-285
-2% -$9.79K 0.01% 1016
2023
Q2
$425K Sell
11,632
-1,138
-9% -$34.7K 0.01% 917
2023
Q1
$382K Sell
12,770
-19,501
-60% -$642K 0.01% 937
2022
Q4
$988K Sell
32,271
-2,779
-8% -$83.4K 0.02% 575
2022
Q3
$864K Buy
35,050
+6,380
+22% +$210K 0.02% 582
2022
Q2
$918K Sell
28,670
-6,040
-17% -$222K 0.02% 593
2022
Q1
$1.09M Sell
34,710
-1,350
-4% -$42.2K 0.02% 590
2021
Q4
$1.21M Buy
36,060
+19,550
+118% +$609K 0.03% 568
2021
Q3
$480K Sell
16,510
-110
-0.7% -$3.56K 0.01% 941
2021
Q2
$578K Buy
16,620
+2,610
+19% +$86.4K 0.01% 843
2021
Q1
$391K Buy
14,010
+20
+0.1% +$532 0.01% 1028
2020
Q4
$347K Sell
13,990
-8,920
-39% -$212K 0.01% 1019
2020
Q3
$479K Sell
22,910
-30
-0.1% -$579 0.01% 785
2020
Q2
$352K Buy
22,940
+2,790
+14% +$35.3K 0.01% 923
2020
Q1
$179K Hold
20,150
– – 0.01% 1089
2019
Q4
$365K Sell
20,150
-440
-2% -$7.31K 0.01% 1001
2019
Q3
$308K Sell
20,590
-1,550
-7% -$25.2K 0.01% 1045
2019
Q2
$531K Sell
22,140
-900
-4% -$26.5K 0.01% 781
2019
Q1
$856K Buy
23,040
+500
+2% +$18.2K 0.02% 592
2018
Q4
$636K Buy
22,540
+2,620
+13% +$82.9K 0.02% 662
2018
Q3
$786K Hold
19,920
– – 0.02% 707
2018
Q2
$884K Sell
19,920
-150
-0.7% -$7.46K 0.02% 647
2018
Q1
$978K Sell
20,070
-1,250
-6% -$62.5K 0.03% 622
2017
Q4
$1.07M Buy
21,320
+2,710
+15% +$142K 0.03% 624
2017
Q3
$942K Buy
+18,610
New +$878K 0.02% 634
2016
Q3
$942K Buy
+18,610
New +$213K 0.02% 634

Other funds holding CC

Crossmark Global Holdings's CC Position: Q3 2024 in Review

Crossmark Global Holdings sold out of Chemours (CC) in Q3 2024, closing a stake of 9,612 shares — an estimated $216K sold.

Crossmark Global Holdings first reported a position in CC in Q3 2016 and held it in 29 quarters. The position peaked at $1.21M in Q4 2021. 422 funds tracked by Wall St. Rank hold CC as of Q3 2024.

  • Crossmark Global Holdings reported no remaining Chemours position as of Q3 2024 after selling out during the quarter.
  • Crossmark Global Holdings sold 9,612 Chemours shares in Q3 2024, an estimated $216K.
  • Crossmark Global Holdings first reported a position in Chemours in Q3 2016 and held it in 29 quarters.
  • Crossmark Global Holdings's Chemours position peaked at $1.21M in Q4 2021.
  • 422 funds tracked by Wall St. Rank held Chemours as of Q3 2024.

Based on Crossmark Global Holdings's 13F filing for Q3 2024, filed 4 Nov 2024.